These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21868487

  • 1. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV, Kragt JJ, Knol DL, Polman CH, Uitdehaag BM.
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [Abstract] [Full Text] [Related]

  • 2. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
    Bosma L, Kragt JJ, Polman CH, Uitdehaag BM.
    Mult Scler; 2013 Mar; 19(3):326-33. PubMed ID: 22907939
    [Abstract] [Full Text] [Related]

  • 3. The search for responsive clinical endpoints in primary progressive multiple sclerosis.
    Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, Thompson AJ, Tintoré M, Uitdehaag BM.
    Mult Scler; 2009 Jun; 15(6):715-20. PubMed ID: 19383646
    [Abstract] [Full Text] [Related]

  • 4. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [Abstract] [Full Text] [Related]

  • 5. Detecting clinically-relevant changes in progressive multiple sclerosis.
    Bosma LV, Sonder JM, Kragt JJ, Polman CH, Uitdehaag BM.
    Mult Scler; 2015 Feb 25; 21(2):171-9. PubMed ID: 25013153
    [Abstract] [Full Text] [Related]

  • 6. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D, Cohen JA, Freedman MS, Goldman MD, Hartung HP, Havrdova E, Jeffery D, Kapoor R, Miller A, Sellebjerg F, Kinch D, Lee S, Shang S, Mikol D.
    Mult Scler; 2017 Jan 25; 23(1):94-105. PubMed ID: 27003945
    [Abstract] [Full Text] [Related]

  • 7. The natural history of primary progressive MS in British Columbia, Canada.
    Tremlett H, Paty D, Devonshire V.
    Neurology; 2005 Dec 27; 65(12):1919-23. PubMed ID: 16380613
    [Abstract] [Full Text] [Related]

  • 8. Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
    Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, Thompson AJ, Tintoré M, Uitdehaag BM.
    Mult Scler; 2010 Jul 27; 16(7):862-7. PubMed ID: 20488826
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
    Khaleeli Z, Ciccarelli O, Mizskiel K, Altmann D, Miller DH, Thompson AJ.
    Mult Scler; 2010 Mar 27; 16(3):317-24. PubMed ID: 20203148
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S.
    Neurorehabil Neural Repair; 2011 Sep 27; 25(7):672-9. PubMed ID: 21436388
    [Abstract] [Full Text] [Related]

  • 13. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL, Bueno AM, Devonshire V, Tremlett H, UBC MS Clinic Neurologists.
    Mult Scler; 2011 Nov 27; 17(11):1375-83. PubMed ID: 21677023
    [Abstract] [Full Text] [Related]

  • 14. Improving gait in multiple sclerosis using robot-assisted, body weight supported treadmill training.
    Lo AC, Triche EW.
    Neurorehabil Neural Repair; 2008 Nov 27; 22(6):661-71. PubMed ID: 18971381
    [Abstract] [Full Text] [Related]

  • 15. Prediction of long-term disability in multiple sclerosis.
    Schlaeger R, D'Souza M, Schindler C, Grize L, Dellas S, Radue EW, Kappos L, Fuhr P.
    Mult Scler; 2012 Jan 27; 18(1):31-8. PubMed ID: 21868486
    [Abstract] [Full Text] [Related]

  • 16. Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
    Enzinger C, Fuchs S, Pichler A, Wallner-Blazek M, Khalil M, Langkammer C, Ropele S, Fazekas F.
    Mult Scler; 2011 Jun 27; 17(6):695-701. PubMed ID: 21228028
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets.
    Koch MW, Mostert J, Uitdehaag B, Cutter G.
    Mult Scler; 2020 Oct 27; 26(12):1540-1549. PubMed ID: 31517591
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL, Devonshire V, Tremlett H.
    Neurology; 2007 Feb 13; 68(7):496-500. PubMed ID: 17296915
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Self-rated physical health predicts change in disability in multiple sclerosis.
    Drulovic J, Riise T, Nortvedt M, Pekmezovic T, Manigoda M.
    Mult Scler; 2008 Aug 13; 14(7):999-1002. PubMed ID: 18505776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.